Sensitivity and responsiveness of the EQ-5D-3L in patients with uncontrolled focal seizures: an analysis of Phase III trials of adjunctive brivaracetam-Reference-Cited by-同舟云学术

Sensitivity and responsiveness of the EQ-5D-3L in patients with uncontrolled focal seizures: an analysis of Phase III trials of adjunctive brivaracetam

Published:2016-12-21 Issue:3 Volume:26 Page:749-759
ISSN:0962-9343
Container-title:Quality of Life Research
language:en
Short-container-title:Qual Life Res

Author:

Mukuria Clara^ORCID,Young Tracey,Keetharuth Anju,Borghs Simon,Brazier John

Funder

UCB Pharma

Publisher

Springer Science and Business Media LLC

Subject

Public Health, Environmental and Occupational Health

Link

http://link.springer.com/content/pdf/10.1007/s11136-016-1483-3.pdf

Reference27 articles.

1. Fisher, R. S., van Emde, B. W., Blume, W., Elger, C., Genton, P., Lee, P., et al. (2005). Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia, 46(4), 470–472.

2. Jacoby, A., & Baker, G. A. (2008). Quality-of-life trajectories in epilepsy: A review of the literature. Epilepsy & Behavior, 12(4), 557–571. doi: 10.1016/j.yebeh.2007.11.013 .

3. Cockerell, O. C., Johnson, A. L., Sander, J. W., & Shorvon, S. D. (1997). Prognosis of epilepsy: A review and further analysis of the first nine years of the British National General Practice Study of Epilepsy, a prospective population-based study. Epilepsia, 38(1), 31–46.

4. Kwan, P., & Brodie, M. J. (2000). Early identification of refractory epilepsy. New England Journal of Medicine, 342(5), 314–319.

5. NICE. (2013). Guide to the methods of technology appraisal 2013. Process and methods guides (Vol. 2016). London: NICE.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of Seizure Dogs for People With Severe Refractory Epilepsy;Neurology;2024-03-26

2. Mapping analysis to predict SF-6D utilities from health outcomes in people with focal epilepsy;The European Journal of Health Economics;2022-10-19

3. EuroQOL-5D-3L does not adequately map quality-of-life deterioration in severely affected patients with epilepsy;Epilepsy & Behavior;2022-02

4. Patient and Caregiver Health State Utilities in Lennox-Gastaut Syndrome and Dravet Syndrome;Clinical Therapeutics;2021-11

5. Good Days and Bad Days: Measuring Health-Related Quality of Life in People With Epilepsy;Value in Health;2021-10